Preventing antimicrobial-resistant bacterial infections in surgical patients

Surgical Infections

Volumn 3, Issue 4, 2002, Pages 375-385

  Raymond, Daniel P ^a   Kuehnert, Matthew J ^b   Sawyer, Robert G ^a  

^a UNIVERSITY OF VIRGINIA   (United States)

^b NATIONAL CENTER FOR EMERGING AND ZOONOTIC INFECTIOUS DISEASES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; AZITHROMYCIN; CARBAPENEM; CEFEPIME; CEFOTETAN; CEFOXITIN; CEFTAZIDIME; CEPHALOSPORIN; CEPHALOSPORIN DERIVATIVE; CIPROFLOXACIN; CLARITHROMYCIN; COTRIMOXAZOLE; GENTAMICIN; LEVOFLOXACIN; MACROLIDE; METICILLIN; PIPERACILLIN PLUS TAZOBACTAM; QUINOLINE DERIVED ANTIINFECTIVE AGENT; SULTAMICILLIN; TOBRAMYCIN; VANCOMYCIN;

ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIAL INFECTION; CATHETERIZATION; CLINICAL PRACTICE; DIAGNOSTIC ACCURACY; DISEASE TRANSMISSION; DRUG UTILIZATION; HEALTH CARE; HEALTH CARE ORGANIZATION; HEALTH CARE PLANNING; HEALTH PROGRAM; HEPATITIS B; HUMAN; INFECTION PREVENTION; KIDNEY DISEASE; MORBIDITY; MORTALITY; PEER REVIEW; PNEUMONIA; PRACTICE GUIDELINE; PRIORITY JOURNAL; SURGICAL INFECTION; URINARY TRACT INFECTION; VACCINATION;

EID: 0344022560     PISSN: 10962964     EISSN: None     Source Type: Journal    
DOI: 10.1089/109629602762539599     Document Type: Article

References (101)

1. Cohen ML. Epidemiology of drug resistance: implications for a post-antimicrobial era. Science 1992;257: 1050-1055.
2. Acar JF. Consequences of bacterial resistance to antibiotics in medical practice. Clin Infect Dis 1997; 24(Suppl 1):S17-18.
3. Carbon C. Costs of treating infections caused by methicillin-resistant staphylococci and vancomycin-resistant enterococci. J Antimicrob Chemother 1999; 44(Suppl A):31-36.
4. Gleason TG, Crabtree TD, Pelletier SJ, et al. Prediction of poorer prognosis by infection with antibiotic-resistant gram-positive cocci than by infection with antibiotic-sensitive strains. Arch Surg 1999;134: 1033-1040.
5. Shlaes DM, Gerding DN, John JF Jr., et al. Society for Healthcare Epidemiology of America and Infectious Diseases Society of America Joint Committee on the Prevention of Antimicrobial Resistance: guidelines for the prevention of antimicrobial resistance in hospitals. Clin Infect Dis 1997;25:584-599.
6. American Society for Microbiology (ASM). Report of the ASM task force on antibiotic resistance. Antimicrob Agents Chemother 1995;39:1-23.
7. Malangoni MA, Condon RE, Spiegel CA. Treatment of intra-abdominal infections is appropriate with single-agent or combination antibiotic therapy. Surgery 1985;98:648-655.
8. Christou NV, Turgeon P, Wassef R, et al. Management of intra-abdominal infections. The case for intraoperative cultures and comprehensive broadspectrum antibiotic coverage. The Canadian Intraabdominal Infection Study Group. Arch Surg 1996; 131:1193-1201.
9. Postier RG. Antibiotic-resistant organism infection. Am Surg 2000;66:112-116.
10. Richards MJ, Edwards JR, Culver DH, et al. Nosocomial infections in medical intensive care units in the United States. National Nosocomial Infections Surveillance System. Crit Care Med 1999;27:887-892.
11. Pittet D, Harbarth S, Ruef C, et al. Prevalence and risk factors for nosocomial infections in four university hospitals in Switzerland. Infect Control Hosp Epidemiol 1999;20:37-42.
12. Arnow PM, Quimosing EM, Beach M. Consequences of intravascular catheter sepsis. Clin Infect Dis 1993; 16:778-784.
13. Pittet D, Tarara D, Wenzel RP. Nosocomial bloodstream infection in critically ill patients. Excess length of stay, extra costs, and attributable mortality. JAMA 1994;271:1598-1601.
14. Smith RL, Meixler SM, Simberkoff MS. Excess mortality in critically ill patients with nosocomial bloodstream infections. Chest 1991;100:164-167.
15. Darouiche RO, Raad, II, Heard SO, et al. A comparison of two antimicrobial-impregnated central venous catheters. Catheter Study Group. N Engl J Med 1999;340:1-8.
16. Veenstra DL, Saint S, Saha S, et al. Efficacy of antiseptic-impregnated central venous catheters in preventing catheter-related bloodstream infection: A meta-analysis. JAMA 1999;281:261-267.
17. Boswald M, Lugauer S, Regenfus A, et al. Reduced rates of catheter-associated infection by use of a new silver-impregnated central venous catheter. Infection 1999;27:S56-60.
18. Collin GR. Decreasing catheter colonization through the use of an antiseptic-impregnated catheter: a continuous quality improvement project. Chest 1999; 115:1632-1640.
19. Paradisi F, Corti G, Mangani V. Urosepsis in the critical care unit. Crit Care Clin 1998;14:165-80.
20. Wright SW, Wrenn KD, Haynes M, et al. Prevalence and risk factors for multidrug resistant uropathogens in ED patients. Am J Emerg Med 2000;18: 143-146.
21. Garibaldi RA. Hospital-acquired urinary tract infections. In Wenzel RP, ed. Prevention and Control of Nosocomial Infection. Baltimore: Williams & Wilkins, 1993:600-613.
22. Liedberg H, Lundeberg T. Silver alloy coated catheters reduce catheter-associated bacteriuria. Br J Urol 1990;65:379-381.
23. Rosch W, Lugauer S. Catheter-associated infections in urology: possible use of silver-impregnated catheters and the Erlanger silver catheter. Infection 1999;27:S74-77.
24. Riley DK, Classen DC, Stevens LE, et al. A large randomized clinical trial of a silver-impregnated urinary catheter: lack of efficacy and staphylococcal superinfection. Am J Med 1995;98:349-356.
25. Darouiche RO, Smith JA Jr, Hanna H, et al. Efficacy of antimicrobial-impregnated bladder catheters in reducing catheter-associated bacteriuria: a prospective, randomized, multicenter clinical trial. Urology 1999;54:976-981.
26. Saint S, Elmore JG, Sullivan SD, et al. The efficacy of silver alloy-coated urinary catheters in preventing urinary tract infection: a meta-analysis. Am J Med 1998;105:236-241.
27. Barie PS. Importance, morbidity, and mortality of pneumonia in the surgical intensive care unit. Am J Surg 2000;179:2S-7S.
28. Chastre J, Fagon JY, Trouillet JL. Diagnosis and treatment of nosocomial pneumonia in patients in intensive care units. Clin Infect Dis 1995;21(Suppl 3): S226-237.
29. Crabtree TD, Pelletier SJ, Gleason TG, et al. Gender-dependent differences in outcome after the treatment of infection in hospitalized patients. JAMA 1999;282:2143-2148.
30. Sheldon GF, Croom RD, Meyer AA. The spleen. In: Sabiston DC, ed. Sabiston Textbook of Surgery. Vol. 15. Philadelphia: W.B. Saunders Company, 1997: 1187-1214.
31. Kind EA, Craft C, Fowles JB, et al. Pneumococcal vaccine administration associated with splenectomy: missed opportunities. Am J Infect Control 1998;26: 418-422.
32. Bolyard EA, Tablan OC, Williams WW, et al. Guideline for infection control in healthcare personnel, 1998. Hospital Infection Control Practices Advisory Committee. Infect Control Hosp Epidemiol 1998; 19:407-463.
33. Orenstein WA, Wharton M, Bart KJ, et al. Immunization. In: Mandell GL, Bennett JE, Dolin R, eds. Principles and Practice of Infectious Diseases. Philadelphia: Churchill Livingstone, 2000:3207-3231.
34. Bohnen JM, Marshall JC, Fry DE, et al. Clinical and scientific importance of source control in abdominal infections: Summary of a symposium. Can J Surg 1999;42:122-126.
35. Fagon JY, Chastre J, Wolff M, et al. Invasive and non-invasive strategies for management of suspected ventilator-associated pneumonia. A randomized trial. Ann Intern Med 2000;132:621-630.
36. Baughman RP, Conrado CE. Diagnosis of lower respiratory tract infections: what we have and what would be nice. Chest 1998;113:219S-223S.
37. Croce MA, Fabian TC, Waddle-Smith L, et al. Utility of Gram's stain and efficacy of quantitative cultures for posttraumatic pneumonia: a prospective study. Ann Surg 1998;227:743-751.
38. Kirtland SH, Corley DE, Winterbauer RH, et al. The diagnosis of ventilator-associated pneumonia: a comparison of histologic, microbiologic, and clinical criteria. Chest 1997;112:445-457.
39. Mosdell DM, Morris DM, Voltura A, et al. Antibiotic treatment for surgical peritonitis. Ann Surg 1991; 214:543-549.
40. Montravers P, Gauzit R, Muller C, et al. Emergence of antibiotic-resistant bacteria in cases of peritonitis after intraabdominal surgery affects the efficacy of empirical antimicrobial therapy. Clin Infect Dis 1996;23:486-494.
41. Kokoska ER, Silen ML, Tracy TF Jr, et al. The impact of intracoperative culture on treatment and outcome in children with perforated appendicitis. J Pediatr Surg 1999;34:749-753.
42. Mosdell DM, Morris DM, Fry DE. Peritoneal cultures and antibiotic therapy in pediatric perforated appendicitis. Am J Surg 1994;167:313-316.
43. Dougherty SH. Antimicrobial culture and susceptibility testing has little value for routine management of secondary bacterial peritonitis. Clin Infect Dis 1997;25(Suppl 2):S258-261.
44. Gruson D, Hilbert G, Vargas F, et al. Rotation and restricted use of antibiotics in a medical intensive care unit. Impact on the incidence of ventilator-associated pneumonia caused by antibiotic-resistant gram-negative bacteria. Am J Respir Crit Care Med 2000;162:837-843.
45. Kollef MH, Ward S, Sherman G, et al. Inadequate treatment of nosocomial infections is associated with certain empiric antibiotic choices. Crit Care Med 2000;28:3456-3464.
46. Raymond DP, Pelletier SJ, Crabtree TD, et al. Impact of a rotating empiric antibiotic schedule on infectious mortality in an intensive care unit. Crit Care Med 2001;29:1101-1108.
47. Kollef MH, Vlasnik J, Sharpless L, et al. Scheduled change of antibiotic classes: a strategy to decrease the incidence of ventilator-associated pneumonia. Am J Respir Crit Care Med 1997;156:1040-1048.
48. King JW, White MC, Todd JR, et al. Alterations in the microbial flora and in the incidence of bacteremia at a university hospital after adoption of amikacin as the sole formulary aminoglycoside. Clin Infect Dis 1992;14:908-915.
49. Seppala H, Klaukka T, Vuopio-Varkila J, et al. The effect of changes in the consumption of macrolide antibiotics on erythromycin resistance in group A streptococci in Finland. Finnish Study Group for Antimicrobial Resistance. N Engl J Med 1997;337: 441-446.
50. Young EJ, Sewell CM, Koza MA, et al. Antibiotic resistance patterns during aminoglycoside restriction. Am J Med Sci 1985;290:223-227.
51. Gerding DN, Larson TA, Hughes RA, et al. Aminoglycoside resistance and aminoglycoside usage: ten years of experience in one hospital. Antimicrob Agents Chemother 1991;35:1284-1290.
52. Stratton CW, Ratner H, Johnston PE, et al. Focused microbiologic surveillance by specific hospital unit: practical application and clinical utility. Clin Ther 1993;15:12-20.
53. Pierson CL, Friedman BA. Comparison of susceptibility to beta-lactam antimicrobial agents among bacteria isolated from intensive care units. Diagn Microbiol Infect Dis 1992;15:19S-30S.
54. Shay DK, Maloney SA, Montecalvo M, et al. Epidemiology and mortality risk of vancomycin-resistant enterococcal bloodstream infections. J Infect Dis 1995;172:993-1000.
55. Mangram AJ, Horan TC, Pearson ML, et al. Guideline for prevention of surgical site infection, 1999. Centers for Disease Control and Prevention (CDC) Hospital Infection Control Practices Advisory Committee. Am J Infect Control 1999;27:97-132.
56. Burke JF. The effective period of preventitive antibiotic action in experimental incisions and dermal lesions. Surgery 1969;66:161-168.
57. Polk HC Jr, Christmas AB. Prophylactic antibiotics in surgery and surgical wound infections. Am Surg 2000;66:105-111.
58. Page CP, Bohnen JM, Fletcher JR, et al. Antimicrobial prophylaxis for surgical wounds. Guidelines for clinical care. Arch Surg 1993;128:79-88.
59. National Academy of Sciences, National Research Council, Division of Medical Sciences, Ad Hoc Committee on Trauma. Postoperative wound infections: the influence of ultraviolet irradiation on the operating room and various other factors. Ann Surg 1964;160:1-196.
60. Polk HC Jr, Lopez-Mayor JF. Postoperative wound infection: a prospective study of determinant factors and prevention. Surgery 1969;66:97-103.
61. DiPiro JT, Vallner JJ, Bowden TA Jr, et al. Intraoperative serum and tissue activity of cefazolin and cefoxitin. Arch Surg 1985;120:829-832.
62. Bergamini TM, Polk HC Jr. Pharmacodynamics of antibiotic penetration of tissue and surgical prophylaxis. Surg Gynecol Obstet 1989;168:283-289.
63. Galandiuk S, Polk HC Jr, Jagelman DG, et al. Re-emphasis of priorities in surgical antibiotic prophylaxis. Surg Gynecol Obstet 1989;169:219-222.
64. Classen DC, Evans RS, Pestotnik SL, et al. The timing of prophylactic administration of antibiotics and the risk of surgical-wound infection. N Engl J Med 1992;326:281-286.
65. Dellinger EP, Gross PA, Barrett TL, et al. Quality standard for antimicrobial prophylaxis in surgical procedures. The Infectious Diseases Society of America. Infect Control Hosp Epidemiol 1994;15:182-188.
66. Swoboda SM, Merz C, Kostuik J, et al. Does intra-operative blood loss affect antibiotic serum and tissue concentrations? Arch Surg 1996;131:1165-1171.
67. Higgins AF, Lewis A, Noone P, et al. Single and multiple dose cotrimoxazole and metronidazole in colorectal surgery. Br J Surg 1980;67:90-92.
68. Giercksky KE, Danielsen S, Garberg O, et al. A single dose tinidazole and doxycycline prophylaxis in elective surgery of colon and rectum. A prospective controlled clinical multicenter study. Ann Surg 1982;195:227-231.
69. DiPiro JT, Cheung RP, Bowden TA Jr, et al. Single dose systemic antibiotic prophylaxis of surgical wound infections. Am J Surg 1986;152:552-559.
70. Harbarth S, Samore MH, Lichtenberg D, et al. Prolonged antibiotic prophylaxis after cardiovascular surgery and its effect on surgical site infections and antimicrobial resistance. Circulation 2000;101: 2916-2921.
71. Gorecki P, Schein M, Rucinski JC, et al. Antibiotic administration in patients undergoing common surgical procedures in a community teaching hospital: The chaos continues. World J Surg 1999;23:429-432.
72. Waddell TK, Rotstein OD. Antimicrobial prophylaxis in surgery. Committee on Antimicrobial Agents, Canadian Infectious Disease Society. CMAJ 1994;151:925-931.
73. Ratto GB, Fantino G, Tassara E, et al. Long-term antimicrobial prophylaxis in lung cancer surgery: Correlation between microbiological findings and empyema development. Lung Cancer 1994;11:345-352.
74. Ericsson CD, Fischer RP, Rowlands BJ, et al. Prophylactic antibiotics in trauma: the hazards of underdosing. J Trauma 1989;29:1356-1561.
75. Condon RE, Wittmann DH. The use of antibiotics in general surgery. Curr Probl Surg 1991;28:801-949.
76. Fry DE. The importance of antibiotic pharmacokinetics in critical illness. Am J Surg 1996;172:20S-25S.
77. van Dalen R, Vree TB. Pharmacokinetics of antibiotics in critically ill patients. Intensive Care Med 1990;16:S235-S238.
78. Zaske DE, Sawchuk RJ, Strate RG. The necessity of increased doses of amikacin in burn patients. Surgery 1978;84:603-608.
79. Zaske DE, Cipolle RJ, Strate RJ. Gentamicin dosage requirements: wide interpatient variations in 242 surgery patients with normal renal function. Surgery 1980;87:164-169.
80. Tang GJ, Tang JJ, Lin BS, et al. Factors affecting gentamicin pharmacokinetics in septic patients. Acta Anaesthesiol Scand 1999;43:726-730.
81. Gomez CM, Cordingly JJ, Palazzo MG. Altered pharmacokinetics of ceftazidime in critically ill patients. Antimicrob Agents Chemother 1999;43:1798-1802.
82. Joukhadar C, Frossard M, Mayer BX, et al. Impaired target site penetration of beta-lactams may account for therapeutic failure in patients with septic shock. Crit Care Med 2001;29:385-391.
83. Reed RL, Wu AH, Miller-Crotchett P, et al. Pharmacokinetic monitoring of nephrotoxic antibiotics in surgical intensive care patients. J Trauma 1989;29: 1462-1468.
84. Plaisance KI, Quintiliani R, Nightingale CH. The pharmacokinetics of metronidazole and its metabolites in critically ill patients. J Antimicrob Chemother 1988;21:195-200.
85. Polk HC Jr. Factors influencing the risk of infection after trauma. Am J Surg 1993;165:2S-7S.
86. Schein M, Assalia A, Bachus H. Minimal antibiotic therapy after emergency abdominal surgery: A prospective study. Br J Surg 1994;81:989-991.
87. Schein M, Wittmann DH, Lorenz W. Duration of antibiotic treatment in surgical infections of the abdomen. Forum statement: A plea for selective and controlled postoperative antibiotic administration. Eur J Surg Suppl 1996;576:66-69.
88. Hadjiminas D, Cheadle WG, Spain DA, et al. Antibiotic overkill of trauma victims? Am J Surg 1994; 168:288-290.
89. Wittmann DH, Schein M. Let us shorten antibiotic prophylaxis and therapy in surgery. Am J Surg 1996;172:26S-32S.
90. Farber MS, Abrams JH. Antibiotics for the acute abdomen. Surg Clin North Am 1997;77:1395-1417.
91. Bischoff WE, Reynolds TM, Sessler CN, et al. Handwashing compliance by health care workers: The impact of introducing an accessible, alcohol-based hand antiseptic. Arch Intern Med 2000;160: 1017-1021.
92. Nystrom B. Impact of handwashing on mortality in intensive care: Examination of the evidence. Infect Control Hosp Epidemiol 1994;15:435-436.
93. Wenzel RP, Pfaller MA. Handwashing: efficacy versus acceptance. A brief essay. J Hosp Infect 1991; 18(Suppl B):65-68.
94. Centers for Disease Control and Prevention (CDC). Recommendations for preventing the spread of vancomycin resistance. Recommendations of the Hospital Infection Control Practices Advisory Committee (HICPAC). MMWR 1995;44(RR12):1-13.
95. Garner JS. Guideline for isolation precautions in hospitals. The Hospital Infection Control Practices Advisory Committee. Infect Control Hosp Epidemiol 1996;17:53-80.
96. Centers for Disease Control and Prevention. Guideline for hand hygiene in health-care settings: Recommendations for the Healthcare Infection Control Practices Advisory Committee and the HICPAC/SHEA/APIC/IDSA Hand Hygiene Task Force. MMWR 2002;51(RR16):1-45.
97. Centers for Disease Control and Prevention. Guidelines for the prevention of intravascular catheter-related infections. MMWR 2002;51(RR10):1-29.
98. Wong ES. Guideline for prevention of catheter-associated urinary tract infections. Am J Infect Control 1983;11:28-36.
99. Tablan OC, Anderson LJ, Arden NH, et al. Guideline for prevention of nosocomial pneumonia. The Hospital Infection Control Practices Advisory Committee, Centers for Disease Control and Prevention. Infect Control Hosp Epidemiol 1994;15: 587-627.
100. Haley RW, Culver DH, Morgan WM, et al. Identifying patients at high risk of surgical wound infection. A simple multivariate index of patient susceptibility and wound contamination. Am J Epidemiol 1985; 121:206-215.
101. Fabian TC. Prevention of infections following penetrating abdominal trauma. Am J Surg 1993;165: 14S-19S.